Investors and Media Relations
The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.
We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.
| Infinity Pharmaceuticals (NASDAQ: INFI) |
4:16 PM ET on Jul 2, 2009 |
| Last Price |
Change |
Open |
Day High |
52-Week High |
5.42 |
0.28  (4.91%) |
5.60 |
5.79 |
8.87 |
| Volume |
Previous Close |
Day Low |
52-Week Low |
| 80,100 |
5.70 |
5.40 |
3.74 |
Annual Report
Click here to view the 2008 Annual Report
Recent Releases
Jun 29, 2009
Infinity Pharmaceuticals Added to Russell 2000(r) Index
May 30, 2009
Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009
more »
|
